Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-07-31 Option Award | 2024-08-01 5:40 pm | N/A N/A | MCKESSON CORP | MCK | Dunsire Deborah Director | 349 | $0 | 349 (Direct) | View |
| 2024-06-18 Option Award | 2024-06-20 2:29 pm | N/A 2034-06-18 | Ultragenyx Pharmaceutical Inc. | RARE | Dunsire Deborah Director | 15,245 | $0 | 34,975 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:30 pm | N/A 2034-06-04 | Syros Pharmaceuticals Inc. | SYRS | Dunsire Deborah Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-06-03 Option Award | 2024-06-04 4:42 pm | N/A N/A | MCKESSON CORP | MCK | Dunsire Deborah Director | 56 | $0 | 56 (Direct) | View |
| 2024-06-01 Exercise | 2024-06-04 4:42 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Dunsire Deborah Director | 4,000 | $0 | 12,000 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-09 2:29 pm | N/A 2033-06-07 | Ultragenyx Pharmaceutical Inc. | RARE | Dunsire Deborah Director | 10,970 | $0 | 26,840 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-02 4:23 pm | N/A 2033-05-31 | Syros Pharmaceuticals Inc. | SYRS | Dunsire Deborah Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2022-09-16 Option Award | 2022-09-19 5:08 pm | N/A 2032-09-15 | Syros Pharmaceuticals Inc. | SYRS | Dunsire Deborah Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-24 Option Award | 2022-06-28 1:48 pm | N/A 2032-06-24 | Ultragenyx Pharmaceutical Inc. | RARE | Dunsire Deborah Director | 9,545 | $0 | 22,115 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-02 7:10 pm | N/A 2032-05-31 | Syros Pharmaceuticals Inc. | SYRS | Dunsire Deborah Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2021-09-09 Option Award | 2021-09-10 5:30 pm | N/A 2031-09-08 | Syros Pharmaceuticals Inc. | SYRS | Dunsire Deborah Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2021-07-21 Disposition | 2021-07-23 4:48 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | Dunsire Deborah Director | 14,629 | $0 | 0 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-28 6:25 pm | N/A 2031-06-24 | Ultragenyx Pharmaceutical Inc. | RARE | Dunsire Deborah Director | 6,270 | $0 | 16,695 (Direct) | View |
| 2021-05-20 Option Award | 2021-05-24 4:27 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | Dunsire Deborah Director | 2,495 | $0 | 14,629 (Direct) | View |
| 2020-06-26 Option Award | 2020-06-30 1:10 pm | N/A 2030-06-26 | Ultragenyx Pharmaceutical Inc. | RARE | Dunsire Deborah Director | 6,800 | $0 | 14,675 (Direct) | View |
| 2020-05-14 Option Award | 2020-05-18 5:10 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | Dunsire Deborah Director | 4,409 | $0 | 12,134 (Direct) | View |